Vagus nerve stimulation to treat neurodegenerative disorders
US12172017B2 · kind B2 · utility
0Cited by
299References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 11, 2018 |
| Grant date | Dec 24, 2024 |
| Priority date | — |
| Expiry date | Oct 11, 2038 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/7095
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
Systems, devices, and methods for using vagus nerve stimulation to treat demyelination disorders and/or disorder of the blood brain barrier are described. The vagus nerve stimulation therapy described herein is configured to reduce or prevent demyelination and/or promote remyelination to treat various disorders related to demyelination, such as multiple sclerosis. A low duty cycle stimulation protocol with a relatively short on-time and a relatively long off-time can be used.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.